Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PHF5A modulators(PHD finger protein 5A modulators), SF3B1 inhibitors(Splicing factor 3B subunit 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H25N3O5 |
InChIKeyYCIHYSVUQSOVJT-NLFFAJNJSA-N |
CAS Registry2929223-36-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | 18 Dec 2023 |